rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Otello Stampacchia

Director

Company insider

Files Form 4 as: Director, ImageneBio; Director and 10% owner, Kronos Bio; Director and 10% owner, Replimune Group; Director and 10% owner, Morphic Holding; Chief Executive Officer, Omega Alpha SPAC; Director and 10% owner, Gossamer Bio; Director and 10% owner, Micromet.

Every Form 4 they filed

In numbers

Trades disclosed
182
Buys
5
Sells
81
Bought
$26.6M
Sold
$46.3M
Companies
7
Companies where not an officer
6
First trade
5 May 2006
Last trade
16 Jun 2026
Last filed
18 Jun 2026

Companies traded

Where they are an officer
Omega Alpha SPACDirector, Officer, 10% owner · last 11 Jan 20211 buy · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
IMA ImageneBioDirector · Biotechnology · last 16 Jun 20261 buy · 0 sells
Kronos BioDirector, 10% owner · last 22 Jun 20221 buy · 0 sells
REPL Replimune GroupDirector, 10% owner · Biotechnology · last 23 Sep 20211 buy · 2 sells
Morphic HoldingDirector, 10% owner · last 14 Apr 20211 buy · 26 sells
GOSS Gossamer BioDirector, 10% owner · Biotechnology · last 11 Sep 20190 buys · 2 sells
MicrometDirector, 10% owner · last 4 Mar 20100 buys · 51 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Jun 2026filed 18 Jun 2026IMA ImageneBiooption or derivative · BiotechnologySEC FORM 4 Code A—15,600 at $0.00filing
16 Jun 2026filed 18 Jun 2026IMA ImageneBiooption or derivative · BiotechnologySEC FORM 4 Code A—15,600 at $0.00filing
25 Jul 2025filed 30 Jul 2025IMA ImageneBiooption or derivative · BiotechnologySEC FORM 4 Code M—17,520 at $0.00filing
25 Jul 2025filed 30 Jul 2025IMA ImageneBioBiotechnologySEC FORM 4 Code M—379filing
25 Jul 2025filed 30 Jul 2025IMA ImageneBioBiotechnologySEC FORM 4 Bought$8.0M267,556 at $29.90filing
7 Jun 2024filed 10 Jun 2024IMA ImageneBiooption or derivative · BiotechnologySEC FORM 4 Code A—17,520 at $0.00filing
9 Jun 2023filed 13 Jun 2023IMA ImageneBiooption or derivative · BiotechnologySEC FORM 4 Code A—17,520 at $0.00filing
22 Jun 2022filed 29 Jun 2022Kronos Biooption or derivativeSEC FORM 4 Code A—34,000 at $0.00filing
9 Jun 2022filed 13 Jun 2022IMA ImageneBiooption or derivative · BiotechnologySEC FORM 4 Code A—13,419 at $0.00filing
21 Dec 2021filed 23 Dec 2021IMA ImageneBiooption or derivative · BiotechnologySEC FORM 4 Code A—13,419 at $0.00filing
23 Sep 2021filed 27 Sep 2021REPL Replimune GroupBiotechnologySEC FORM 4 Sold$409K12,171 at $33.58filing
22 Jun 2021filed 23 Jun 2021Kronos Biooption or derivativeSEC FORM 4 Code A—20,600 at $0.00filing
14 Apr 2021filed 15 Apr 2021Morphic HoldingSEC FORM 4 Sold$229K4,097 at $55.88filing
14 Apr 2021filed 15 Apr 2021Morphic HoldingSEC FORM 4 Sold$117K2,055 at $56.95filing
14 Apr 2021filed 15 Apr 2021Morphic HoldingSEC FORM 4 Sold$216K3,716 at $58.08filing
14 Apr 2021filed 15 Apr 2021Morphic HoldingSEC FORM 4 Sold$240K4,064 at $58.95filing
13 Apr 2021filed 15 Apr 2021Morphic HoldingSEC FORM 4 Sold$100K1,758 at $56.70filing
13 Apr 2021filed 15 Apr 2021Morphic HoldingSEC FORM 4 Sold$281K4,879 at $57.61filing
13 Apr 2021filed 15 Apr 2021Morphic HoldingSEC FORM 4 Sold$21K367 at $58.25filing
1 Apr 2021filed 2 Apr 2021Morphic HoldingSEC FORM 4 Sold$59K942 at $62.89filing

Sectors

Health Care6
Not placed80

Buys in green, sells in red, by the company’s sector.

Related people

Emily Luisa HillChief Financial Officer · Also traded REPL in the last 90 days
Andrew SchwendenmanChief Accounting Officer · Also traded REPL in the last 90 days
Konstantinos XynosChief Medical Officer · Also traded REPL in the last 90 days
Sushil PatelChief Executive Officer · Also traded REPL in the last 90 days